Didier Dreyfuss1. 1. Intensive Care Medicine Department, Hôpital Louis Mourier, Colombes (Assistance Publique-Hôpitaux de Paris), France. didier.dreyfuss@lmr.ap-hop-paris.fr
Abstract
PURPOSE OF REVIEW: Most critical care physicians believe that randomized, controlled trials provide the best available evidence. This review contends that the importance of randomized, controlled trials was overemphasized and that they do not add more to knowledge and practice than physiologic and observational studies. In addition, protection of both patients and proxies may be less adequately ensured during randomized, controlled trials than during observational studies. RECENT FINDINGS: An analysis of the recent literature on critical care shows that conclusions from randomized, controlled trials are either disputable or do not affect existing practice. In addition, several papers reveal potential conflicts between randomized, controlled trials and ethical principles. SUMMARY: We may see in the future the twilight of randomized, controlled trials in critically ill patients because scientific, ethical, and sociologic substrata will be progressively lacking as will be funding.
PURPOSE OF REVIEW: Most critical care physicians believe that randomized, controlled trials provide the best available evidence. This review contends that the importance of randomized, controlled trials was overemphasized and that they do not add more to knowledge and practice than physiologic and observational studies. In addition, protection of both patients and proxies may be less adequately ensured during randomized, controlled trials than during observational studies. RECENT FINDINGS: An analysis of the recent literature on critical care shows that conclusions from randomized, controlled trials are either disputable or do not affect existing practice. In addition, several papers reveal potential conflicts between randomized, controlled trials and ethical principles. SUMMARY: We may see in the future the twilight of randomized, controlled trials in critically illpatients because scientific, ethical, and sociologic substrata will be progressively lacking as will be funding.
Authors: Michael O Harhay; Jason Wagner; Sarah J Ratcliffe; Rachel S Bronheim; Anand Gopal; Sydney Green; Elizabeth Cooney; Mark E Mikkelsen; Meeta Prasad Kerlin; Dylan S Small; Scott D Halpern Journal: Am J Respir Crit Care Med Date: 2014-06-15 Impact factor: 21.405
Authors: Raban V Jeger; Philip Urban; Shannon M Harkness; Chi-Hong Tseng; Jean-Christophe Stauffer; Thierry H Lejemtel; Lynn A Sleeper; Matthias E Pfisterer; Judith S Hochman Journal: Acute Card Care Date: 2011-01-18